Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VNDA

Vanda Pharmaceuticals Inc

May 22 • 04:00PM ET

6.19

-0.02 -0.32 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: HRMY AXSM NMRA VYGR PRTA

| Held by: VTI XBI IWM VXF IWN IBB VTWO SCHA VFMO DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.05	Insider Own	8.54%	Shs Outstand	60.14M	Perf Week	-1.43%
Market Cap	372.24M	Forward P/E	-	EPS next Y	-0.87	Insider Trans	-6.28%	Shs Float	55.02M	Perf Month	-7.47%
Enterprise Value	183.00M	PEG	-	EPS next Q	-0.60	Inst Own	77.35%	Short Float	11.26%	Perf Quarter	-24.05%
Income	-239.55M	P/S	1.71	EPS this Y	38.45%	Inst Trans	7.71%	Short Ratio	2.61	Perf Half Y	20.43%
Sales	217.78M	P/B	1.33	EPS next Y	62.03%	ROA	-44.97%	Short Interest	6.20M	Perf YTD	-29.82%
Book/sh	4.67	P/C	1.84	EPS next 5Y	45.07%	ROE	-60.48%	52W High	9.94 -37.73%	Perf Year	45.99%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	- -	ROIC	-83.23%	52W Low	4.14 49.52%	Perf 3Y	-0.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-5.29% -2.73%	Gross Margin	89.91%	Volatility	3.70% 4.49%	Perf 5Y	-66.52%
Dividend TTM	-	EV/Sales	0.84	EPS Y/Y TTM	-434.76%	Oper. Margin	-73.64%	ATR (14)	0.31	Perf 10Y	-35.49%
Dividend Ex-Date	-	Quick Ratio	2.15	Sales Y/Y TTM	8.16%	Profit Margin	-109.99%	RSI (14)	39.04	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-62.10%	SMA20	-6.41%	Beta	0.63	Target Price	14.90
Payout	-	Debt/Eq	0.05	Sales Q/Q	3.35%	SMA50	-12.10%	Rel Volume	0.37	Prev Close	6.21
Employees	533	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-0.94%	Avg Volume	2.38M	Price	6.19
IPO	Apr 12, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.19% -5.93%	Trades		Volume	884,186	Change	-0.32%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)